CCDC181 and benign prostatic hyperplasia: CCDC181 was excluded from further analyses because the average DNA methylation for this marker tended to be increased in the BPH group (128.6 ± 529.9 copies/mL) compared to the PCa group (108.5 ± 399.7 copies/mL), thus failing to discriminate between BPH and PCa patients.